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CpG islands (CGIs) are dense clusters of CpG sequences that punctuate the CpG-deficient human genome and associate
with many gene promoters. As CGIs also differ from bulk chromosomal DNA by their frequent lack of cytosine
methylation, we devised a CGI enrichment method based on nonmethylated CpG affinity chromatography. The
resulting library was sequenced to define a novel human blood CGI set that includes many that are not detected by
current algorithms. Approximately half of CGIs were associated with annotated gene transcription start sites, the
remainder being intra- or intergenic. Using an array representing over 17,000 CGIs, we established that 6%–8% of CGIs
are methylated in genomic DNA of human blood, brain, muscle, and spleen. Inter- and intragenic CGIs are
preferentially susceptible to methylation. CGIs showing tissue-specific methylation were overrepresented at numerous
genetic loci that are essential for development, including HOX and PAX family members. The findings enable a
comprehensive analysis of the roles played by CGI methylation in normal and diseased human tissues.
Citation: Illingworth R, Kerr A, DeSousa D, Jørgensen H, Ellis P, et al. (2008) A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol
6(1): e22. doi:10.1371/journal.pbio.0060022
Introduction
DNA methylation in the mammalian genome arises due to
covalent addition of a methyl group to the 59 position of
cytosine in the context of the palindromic dinucleotide, CpG.
This modiﬁcation is established and maintained by a family of
DNA methyltransferases that are essential for development
and viability [1,2]. The pattern of CpG methylation in the
human genome distinguishes two fractions with distinct
properties: a major fraction (;98%), in which CpGs are
relatively infrequent (on average 1 per 100 bp) but highly
methylated (approximately 80% of all CpG sites), and a minor
fraction (,2%) that comprises short stretches of DNA
(;1,000 bp) in which CpG is frequent (;1 per 10 bp) and
methylation-free. The latter are known as CpG islands (CGIs)
and they frequently colocalise with the transcription start
sites (TSSs) of genes [3,4].
Although CGIs are often free of methylation, there are
circumstances in which they become heavily methylated, and
this invariably correlates with silencing of any promoter
within the CGI. Artiﬁcial methylation of CGI promoters has
long been known to extinguish transcription when the
constructs are introduced into living cells [5]. Moreover,
demethylation of endogenous methylated CGIs using DNA
methytransferase inhibitors can restore expression of the
gene [6]. These ﬁndings demonstrate that dense CpG
methylation prevents expression of CGI promoters. Because
of this biological consequence, it is important to know the
extent of CGI methylation in both normal and diseased tissue
states. The classical example is X chromosome inactivation in
placental mammals, during which hundreds of CGI pro-
moters become methylated and contribute to the stability of
gene inactivation on this chromosome [7,8]. Genomic
imprinting can also depend upon differential CGI methyl-
ation between maternal and paternal alleles [9]. Certain
‘‘testis-speciﬁc antigen’’ genes possess CGIs that are methy-
lated in all somatic tissues, but not in testis, where the genes
are expressed [10]. Several additional candidates for CGI
methylation in normal tissues have been reported [11,12], and
the number of cases has recently grown due to large-scale
bisulﬁte sequencing [13] and analysis of promoter methyl-
ation using microarrays [14].
In the cases of X chromosome inactivation and genomic
imprinting, the biological processes were described initially,
and CpG methylation was subsequently implicated through
mechanistic studies. To uncover new biological roles for CGI
methylation in hitherto undiscovered biological processes, it
would be advantageous to comprehensively screen genomic
DNA for methylated CGIs in normal or diseased cell types. A
persistent limitation affecting this kind of approach has been
uncertainty concerning CGI identiﬁcation [15]. The criteria
for designating a sequence as CGI-like are currently
exclusively bioinformatic in nature, relying on the differences
in the base composition and CpG frequencies (observed/
expected) between bulk genomic DNA and CGIs [16,17]. In an
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attempt to address this limitation and create a resource for
future analysis, we developed a method for CGI identiﬁcation
and puriﬁcation based on their lack of CpG methylation in an
otherwise highly methylated genome.
Our method utilised a protein domain with a speciﬁc
afﬁnity for clustered nonmethylated CpG sites [18,19]. Using
this reagent we physically puriﬁed DNA sequences that
contain clusters of nonmethylated CpG-rich DNA from
human blood DNA. Large-scale sequencing of the fraction
identiﬁed a CGI set that was annotated on the ENSEMBL
database. We found that many CGIs in the set were not
associated with promoters of annotated genes, but were
either within transcription units or between genes. By
arraying the intact CGI sequences, we were able to inter-
rogate genomic DNA fractions from several human tissues in
order to identify methylated CGIs. The results revealed large
numbers of CGIs that are methylated in normal human
tissues, many of which showed tissue-speciﬁc methylation.
Results
A Novel Technique for Purification of CpG Islands
To enrich for nonmethylated CpG-rich DNA (CpG islands),
we developed the technique of CXXC afﬁnity puriﬁcation
(CAP). This uses the cysteine-rich CXXC3 domain that has a
high afﬁnity for nonmethylated CpG sites [18,19]. A recombi-
nant CXXC domain from mouse Mbd1[19] was expressed in
bacteria, and its binding speciﬁcity for nonmethylated CpG
sites was conﬁrmed (Figure 1A). The CXXC domain had no
detectable afﬁnity for DNA containing only methylated CpGs
or for DNA lacking CpGs altogether. We linked the CXXC
domain to a sepharose matrix and conﬁrmed that this
fractionated DNA fragments according to CpG density and
methylation status (unpublished data). All DNA bound to the
Figure 1. The Immobilised CXXC Domain Specifically Retains DNA Containing Clusters of Nonmethylated CpGs
(A) EMSA showing the CXXC complex with a DNA probe containing 27 nonmethylated CpG sites. Nonmethylated probe DNA (CG11) or methylated
probe (MeCG11) was incubated with 0, 250, 500, 1,000, or 2,000 ng of recombinant CXXC protein.
(B) A typical elution profile of bulk genomic DNA (blue line) from a CXXC affinity chromatography column. Genomic DNA (100 lg) was applied to the
CXXC affinity matrix (see Methods) in low salt (0.1 M NaCl) and eluted with a gradient of increasing NaCl (red line; see text). Eighteen fractions were
interrogated by PCR (blue lines). The bracket above indicates fractions that were found to contain nonmethylated CGIs.
(C) Elution of specific CGI sequences of known methylation status. Methylated CGIs (NYESO and MAO in females) coelute with bulk genomic DNA (see
bracket) whereas nonmethylated CGIs (P48 and MAO) elute at high NaCl concentration.
doi:10.1371/journal.pbio.0060022.g001
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Author Summary
The human genome contains about 22,000 genes, each encoding
one of the proteins required for human life. A particular cell type
(e.g., blood, skin, etc.) expresses a specific subset of protein genes
and silences the remainder. To shed light on the mechanisms that
cause genes to be activated or shut down, we studied DNA
sequences called ‘‘CpG islands’’ (CGIs). These sequences are found
at over half of all human genes and can exist in either the active or
silent state depending on the presence or absence of methyl groups
on the DNA. We devised a method for purifying all CGIs and showed
that, unexpectedly, only half occur at the beginning of genes near
the promoter, the rest occurring within or between genes. Notably,
methylation of CGIs causes stable gene silencing. We tested 17,000
CGIs in four human tissues and found that 6%–8% were methylated
in each. Genes whose protein products play an essential role during
embryonic development were preferentially methylated, suggesting
that gene expression during development could be regulated by
CGI methylation.
column at 0.1 M salt. Methylated DNA and CpG-poor DNA
eluted at ;0.4 M NaCl, whereas elution of nonmethylated
CpG-rich DNA required 0.6–1.0 M NaCl. To test the
behaviour of CGIs on the column, human genomic DNA
was digested with MseI (TTAA) [20] and fractionated over the
CXXC column (Figure 1B). The reasoning behind use of Mse1
[20] was to cut AT-rich bulk genomic DNA into small
fragments (predicted average ¼ 123 bp), but to leave CGIs
relatively intact (predicted average ¼ 625 bp). As bulk
genomic DNA has a CpG on average every 100 bp, most
Mse1 fragments will have too few CpGs to be retained by the
CXXC matrix. CGIs on the other hand, with 1 CpG per ;10
bp, will give rise to long fragments with many CpGs. Eluted
fractions were interrogated by PCR using primers speciﬁc for
a range of known CGIs and non-CGI sequences (Figure 1C).
For example, the nonmethylated CGI of the P48 gene eluted
at high salt. The X-linked monoamine oxidase (MAO) gene
eluted as a single high salt peak from male genomic DNA
(where it is nonmethylated), but as two separate peaks at high
and low salt when female DNA (with one methylated and one
nonmethylated allele) was fractionated. The CGI associated
with the NYESO testis-speciﬁc antigen gene (methylated in
somatic tissues) eluted from the CXXC column by low salt as
predicted. The data conﬁrm that CAP may be used to purify a
CGI fraction from human genomic DNA.
A Comprehensive CGI Set from Human Blood
Most or all CGIs are in a nonmethylated state in sperm, but
in addition repetitive elements [21] and telomere-proximal
sequences [22], both of which are moderately CpG-rich, are
hypomethylated in sperm DNA. To avoid contamination of
the CGI fraction with sequences that are nonmethylated,
speciﬁcally in germ cells, whole human blood was used as a
source of CGI fragments. Pooled whole blood DNA from
three males was fractionated using the CXXC column. High
salt fractions were pooled, diluted, and re-chromatographed
before cloning in plasmids. The resulting blood CGI library
was analysed by 221,860 sequence reads representing 119,487
genomic templates. These compiled to give 28,013 unique
MseI fragments. Plots of DNA insert length versus either GþC
content or observed/expected CpG frequency (CpG[o/e])
showed that the great majority of clones exhibited a higher
GþC content (average ¼ 62%) and CpG[o/e] (average ¼ 0.71)
than bulk genomic DNA (GþC ¼ 41% and CpG[o/e] ¼ 0.2)
(Figure 2A and 2B). A fraction of small fragments with
sequence characteristics resembling bulk genomic DNA was
detected by these plots. As these probably represent
contamination, we ﬁltered out fragments shorter than 512
bp that had a GC content less than 50% and/or a CpG[o/e] less
than 0.6 (see grey dots in Figure 2A and 2B). The resulting
ﬁnal sequenced set corresponds to 17,387 CGIs and is
annotated on the ENSEMBL genome browser (http://www.
ensembl.org/index.html. DAS sources: ‘‘CPG island clones’’).
The great majority have classical CGI properties (Figure 2C).
Due to their high average GC content, the sequence pass rate
was 69%. Assuming that the unsequenced clones reﬂect the
same proportion of CGIs as those that were sequenced, we
estimate the total number of CGIs in the library as 25,200. It
is likely that a higher proportion of sequence failures affect
bona ﬁde CGIs, as GC-richness is known to interfere with
sequencing. If so, we estimate that the number of human
genomic CGIs may be closer to 30,000.
CGIs are identiﬁed bioinformatically as DNA sequences
with a base composition greater than 50% GþC and a CpG[o/
e] of more than 0.6 [23]. The DNA length over which this
condition applies is critical. Initially the threshold most often
used was 200 bp, whereas 500 bp is now more commonly
applied [17]. These two criteria are formalised as ‘‘NCBI-
relaxed’’ and ‘‘NCBI-strict,’’ respectively (http://www.ncbi.
nlm.nih.gov/mapview/static/humansearch.html#cpg). The re-
laxed algorithm predicts 307,193 CGIs in the human genome,
which includes many repeated sequences and gene exons.
Over 90% of NCBI-relaxed CGIs are not represented in
either our library or the set predicted by the NCBI-strict. This
and other arguments suggest that the great majority (.90%)
are false positives. On the other hand, 77% of clones in the
CGI library match CGIs predicted by the ‘‘NCBI-strict’’
algorithm (Table 1). Examples of the coincidence of NCBI-
strict predicted CGIs and sequenced CGI clones are illus-
trated for the three typical regions of the human genome
(Figure 2D).
Altogether, NCBI-strict identiﬁes 24,163 CGIs in the
human genome, which accords with the adjusted CGI library
estimate of 25,200. The coincidence of these numbers masks
signiﬁcant differences, however, as 23% of CGIs in the library
are not detected by the NCBI-strict algorithm (4,082 out of
17,387; Table 1). Four randomly selected examples of library
CGIs not detected by NCBI-strict (Figure 2D and 2E,
numbered) gave CpG maps resembling CGIs; three of these
coincided with the promoters of annotated protein-coding
genes (Figure 2D and 2E). The presence of bioinformatically
predicted CGIs that are missing from the CGI library is most
probably due to sequence failure of ;31% of library inserts.
Analysis of the CGIs missed by the NCBI-strict algorithm
shows them to be, as expected, signiﬁcantly weaker with
respect to CpG and GþC content than the total set (Figure
S1). It was not obvious, however, that the algorithm could be
easily improved based on this information. Relaxation of the
sequence parameters reduces the number of false negatives,
but leads to increased numbers of false positives. We suggest
that CAP identiﬁes islands that fail the NCBI criteria, but
reduces the false discovery rate by excluding spurious
methylated CpG-rich sequences. Like the majority of CGIs,
most NCBI-missed islands are gene-associated, although with
an increased incidence of intragenic islands (Table S1). The
CGI library therefore includes a signiﬁcant fraction of bona
ﬁde CGIs that are missed by one of the best available
algorithms.
CAP deﬁnes a set of CGIs that is coherent with respect to
clustering of nonmethylated CpG sites. The genomic distri-
bution of these CGI sequences correlates strongly with gene
density (Figure 2F). For example, gene-rich Chromosome 19
is also CGI-rich, whereas gene-poor Chromosome 18 is
correspondingly CGI-poor. With respect to annotated pro-
tein-coding genes, we found that 76% of CGIs are within 1.5
kb of a transcription unit, but only 49% overlap with the TSS
(Table 2). It follows that half of CGIs are not TSS-associated,
but are either within downstream regions of transcription
units (22%) or located in intergenic DNA. Previous studies
have detected CGIs at the TSS of 56% of human protein-
coding genes [24]. As 43.5% of TSSs overlap sequenced CGIs,
we calculate that the sequenced set of 17,387 CGIs represents
78% of the CGI complement. According to this calculation,
the total CGI number would be 22,400, somewhat less than
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Figure 2. A Library of DNA Sequences that Bind Tightly to the CXXC Column Represents a Comprehensive Set of CGIs
(A and B) Plots of fragment length versus GþC content (A) and CpG[o/e] (B) for 28,013 unique Mse1 inserts. Fragments shorter than 512 bp with a GþC
content¼,50% and a CpG[o/e]¼,0.6 (grey dots) were filtered out as contamination. The dashed line indicates the base composition (A) and CpG o/e
(B) of bulk genomic DNA.
(C) A filtered insert set representing 17,387 CGIs shows a discrete distribution that is distant from bulk genomic DNA (black dot).
(D) Three random chromosomal regions showing CGI sequences mapped by ENSEMBL (green bars). Also shown are CGIs predicted by the NCBI-strict
and NCBI-relaxed algorithms (blue bars). The directions of transcription of coding sequences (yellow bars) are arrowed. Numbered CGIs (1–4) represent
sequences not detected by the NCBI-strict algorithm.
(E) CpG maps of the four CGI clones not predicted by NCBI-strict. Transcription start sites in examples 1, 3, and 4 are indicated by arrows. Sequenced
MseI fragments are denoted by dashed lines and CpG sites by vertical black strokes.
(F) The distribution of cloned CGIs (red strokes) on human chromosomes. The number of CGIs on each chromosome is shown (right) and centromeres
are denoted by blue dots.
doi:10.1371/journal.pbio.0060022.g002
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the ﬁgure of 25,200 deduced from the fraction of sequenced
inserts.
MBD Affinity Purification and Blood CGI Methylation
CAP selects CGIs from blood DNA based on their lack of
methylation and therefore excludes the small fraction of CGIs
(,3%) that are fully methylated in somatic cells from the set
[14]. Indeed, CGIs associated with the human testis-speciﬁc
antigen genes [10], which are methylated in somatic tissues,
were not enriched by CAP (Figure 1C) or present in the
library (unpublished data). Despite the absence of these fully
methylated CGIs, we reasoned that the blood CGI library
provides an opportunity to screen for methylation that
affects a fraction of all copies of a speciﬁc CGI in whole blood
DNA. Also, it permits a screen for differential methylation of
CGIs in tissues and cell types other than blood. To investigate
CGI methylation in normal human tissues, we constructed an
array of sequenced CGIs from the library by immobilising
single-stranded PCR-ampliﬁed inserts on glass slides using 59-
aminolink chemistry as described (http://www.sanger.ac.uk/
Projects/Microarrays/arraylab/methods.shtml). As probes for
the array, methylated CGIs were enriched from genomic DNA
using MBD afﬁnity puriﬁcation (MAP), which was shown
previously to efﬁciently bind methylated CGIs [20] (Figure 3A
and 3B). Human male and female blood DNA was MseI-
digested and ligated to universal catch linkers. We veriﬁed by
PCR that afﬁnity fractionation using MAP effectively sepa-
rated known methylated CGIs (XIST on the active X
chromosome and NYESO) from bulk genomic DNA and
nonmethylated CGIs (P48 and XIST on the inactive X
chromosome; see Figure 3B). Male and female DNA fractions
were pooled after two rounds of MAP, ampliﬁed by linker-
mediated PCR, cyanine labeled, and hybridized to the CGI
microarray. Quadruplicate hybridisations (inclusive of cya-
nine dye swaps) gave mean enrichment values (MAP/Input)
that allowed a comparison between male and female
methylated CGI complements. As expected, these were
positively correlated (R¼ 0.865 Pearson correlation) suggest-
ing similar overall patterns. As the library comprises MseI
fragments that sometimes overlap minimally with the cognate
CpG-rich region, we chose to disregard data from spots that
contained DNA with an average CpG frequency (observed/
expected) of less than 0.5. Although the omitted fragments
often denote CGIs, they include too little of the CpG-rich
domain to be reliable for detection of MAP probes. This
reﬁnement reduced the number of analysable CGIs on the
array to 14,318. To assess the relationship between hybrid-
ization signal relative to input and degree of enrichment by
MAP, we measured a selection of CGIs in the probe by
quantitative PCR and compared this data with the M values
(log2 [MAP signal]/[Input signal]) for those sequences (Figure
3C). The results established that M values greater than 1.5
denote CGIs that are signiﬁcantly enriched by MAP and
therefore methylated. CGIs of the BEST1 and R4RL1 genes
were predicted to be nonmethylated (M ¼ 0.2–0.4) and
methylated (M ¼ 2.2–2.8), respectively, based on the array
data. Bisulﬁte genomic sequencing conﬁrmed this expect-
ation (Figure 3G and 3H).
The major difference in CGI methylation between male
and female DNA was expected to be due to X chromosome
inactivation (see also [25]). We therefore compared the
methylation status of CGIs on Chr 16 and Chr X in male
versus female DNA. Chr 16 CGIs did not vary between males
and females, whereas Chr X CGIs were signiﬁcantly enriched
in female DNA as predicted (Figure 3D–3F; Table S2). Studies
of human X chromosome inactivation have indicated that a
proportion of genes escape inactivation and are therefore
expressed from both chromosomes [26,27]. By comparing the
microarray data for a set of inactivated and escaping CGIs, we
found that inactivated genes had signiﬁcantly higherM values
(p-value ¼ 1.213 3105) (Figure 3I). This ﬁnding afﬁrms the
long-standing link between CGI methylation and gene
silencing and validates the present experimental system as a
means of detecting genes that are shut down in this way.
Table 2. Relationship between CGI Library Inserts and Protein-Coding Genes
Type of Overlap Gene Type Total Genes (CGIs) Overlap with CGI (Gene) Percentage Overlap with CGI (TSS) Percentage
Gene Overlap: CGI Protein 21,384 15,118 70.7 9,312 43.5a
All genesb 31,524 15,433 49.0 9,529 30.2
CGI Overlap: Genes Protein 17,387 13,271 76.3 8,491 48.8
All genesb 17,387 13,360 76.8 8,611 49.5
aThis fraction is less than the known fraction of genes with promoter CGIs (56%), because 31% of CGI inserts did not yield DNA sequence.
bAll genes as classified on the ENSMBL genome browser including noncoding RNAs, pseudogenes, VDJ regions, etc.
doi:10.1371/journal.pbio.0060022.t002
Table 1. Comparison of Human Blood CGI Set with Bioinformatic Prediction
Criterion Number of CGIs NCBIrelaxed NCBIstrict CGI
NCBIrelaxed 307,193 307,193 24,163 (7.9%) 16,072 (5.2%)
NCBIstrict 24,163 24,163 (100%) 24163 13,568 (56.2%)
CGI 17,387 15,799 (90%) 13,305 (76.5%) 17,387
http://www.ncbi.nlm.nih.gov/mapview/static/humansearch.html#cpg
doi:10.1371/journal.pbio.0060022.t001
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Figure 3. Use of an Arrayed CGI Library to Detect CGI Methylation in Human Blood DNA
(A) Schematic showing isolation of densely methylated CGIs using MBD affinity purification based on reference [20]. Open and filled circles represent
nonmethylated and methylated CpG sites, respectively.
(B) Examples of retention of known methylated CGIs by MBD affinity chromatography. Methylated XIST and NYESO CGIs elute at high salt concentration,
whereas nonmethylated P48 and female XIST co-elute with bulk genomic DNA (blue line) at low salt concentration (red line).
(C) M values (log2[MBD/Input]).1.5 (dashed vertical arrow) denote DNA fragments enriched by MAP. M values are plotted against the ratio of fragment
abundance in the MAP probe versus input DNA as determined by quantitative PCR. Error bars represent 6 standard deviation.
(D–F) MAP CGI array hybridization identifies CGIs that are methylated on the inactive X chromosome. (D) Probes isolated by MAP from male and female
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Differential CGI Methylation in Human Tissues
Methylation of CGIs on the inactive X chromosome and at
imprinted genes is well known, but CGI methylation at other
chromosomal loci in normal cells and tissues is incompletely
characterized [12,13,28,29,30]. To investigate this issue on a
large scale, we probed CGI arrays with MAP fractions from
genomic DNA (three individuals per pool) of brain, muscle,
spleen, and sperm in addition to blood (Figure 4A). MAP
enrichment of methylated CGIs in sperm DNA consistently
failed to generate enough DNA for labeling using our
standard PCR ampliﬁcation conditions and was therefore
not analysed further. We conclude that the level of CGI
methylation in sperm is far lower than in any of the somatic
tissues. Taking M values greater than 1.5 to signify methyl-
ation, we observed between 5.7% and 8.3% of CGIs
methylated in the somatic tissues that were tested (Figure
4B; Table 3; Dataset S1). Some CGIs were methylated in
common between all the tested somatic tissues, whereas
others were methylated in only one or a subset of the tissues.
We noted that methylated CGIs disproportionately involved
those that are remote from the TSS of an annotated gene. In
the dataset as a whole, only 8% of TSS CGIs showed evidence
of methylation in at least one tissue, whereas 22% of 39 CGIs
were methylated (Table 4). Do the methylated CGIs differ in
sequence characteristics from CGIs that remain methylation-
free? We plotted the CpG[o/e] frequencies of 1,657 CGIs that
acquired methylation in one or more tissues and found a
mean CpG[o/e] of 0.77 compared with 0.75 for methylated
CGIs (Figure 4C). Though statistically signiﬁcant (p-value ¼
1.413e-10) the biological signiﬁcance of this small difference
is unclear.
We checked by bisulﬁte sequence analysis a panel of seven
CGIs with M values suggestive of tissue-speciﬁc methylation
(M values differing between tissues by .0.75). In each case,
bisulﬁte data conﬁrmed the microarray predictions. CGI
I1878 is not associated with an annotated gene (61.5 kb) and
is methylated exclusively in muscle and brain (Figure 4D).
CGI I2985 spans the transcription start site of the SEC31B
gene, whose product is implicated in vesicular trafﬁcking, and
is compositely methylated only in blood and spleen (Figure
4E). CGIs I13406 (Figure 4F) and I12175 (Figure 5A) are
methylated speciﬁcally in muscle. These overlap the pre-
dicted gene 67313 and the 39 end of OSR1. CGI I3654, which is
associated with the promoter region of an annotated PAX6
transcript (Q59GD2), previously shown to contain methylated
CpG sites [31], is speciﬁcally methylated in brain (Figure 5B).
I11878 is a 39 CGI of ZN649 and is only methylated in spleen
(Figure 4G).
Many methylated CGIs were associated with genes that are
essential for development (Figure 5). This was conﬁrmed by
analysis of gene ontology, which showed signiﬁcant over-
representation of genes whose products are involved in
developmental processes, including ectoderm and mesoderm
development, neurogenesis, and segment speciﬁcation (Table
S3). Transcription factors, including homeobox family
members and other DNA binding proteins, were twice as
abundant as expected by chance. Other gene categories did
not show signiﬁcant enrichment. Among the CGIs whose
methylation status was conﬁrmed by bisulﬁte sequencing,
PAX6 is involved in eye development and neurogenesis [32],
the HOXC cluster lays down the embryonic body plan, and
OSR1 is related to a gene involved in Drosophila gut develop-
ment. We examined the extended HOXC and PAX6 loci for
CGI methylation status using the MAP-CGI array data. Our
library identiﬁed 19 CGIs within the 150-kb HOXC gene
cluster of which eight were methylated differentially in blood,
muscle, and spleen (Figure 5C). Brain was the only tissue that
lacked obvious HOXC CGI methylation. Of nine CGIs near
PAX6, two showed differential methylation. In addition to
brain-speciﬁc methylation of the PAX6-Q59GD2 CGI (see
Figure 5B), we observed methylation of a CGI upstream of the
major PAX6 promoter in muscle and brain (Figure 5D).
The majority of CGIs identiﬁed as methylated by MAP-CGI
array hybridization display composite methylation (Figures 3,
4, and 5), whereby DNA strands at a speciﬁc locus were either
heavily methylated or essentially nonmethylated. This can
explain why CGIs that were initially selected by being
nonmethylated in blood DNA (by CAP) nevertheless register
as methylated by MAP-CGI array analysis. One potential
explanation for composite CGI methylation is that different
individuals within the tissue pools exhibit different CGI
methylation. To look for such ‘‘polymorphism,’’ we examined
CGI I5134, which is within the HOXC cluster and shows
composite methylation by bisulﬁte genomic sequencing.
Analysis of individuals by MAP-CGI arrays showed highly
signiﬁcant differences between individual C and individuals
A and B (Figure 5E). This strikingly conﬁrms individual
variability in methylation at this CGI.
Another potential explanation for composite CGI methyl-
ation is that cell types within the tissue sample possess
different CGI methylation proﬁles. Blood, for example,
consists of monocytes and granulocytes, each of which is
subdivided into other cell types. As CGI I2985 was methylated
at about half of DNA strands in blood, we tested the level of
CGI methylation in DNA from monocytes and granulocytes
separately. The results showed that monocytes had high
methylation levels at this CGI, whereas granulocytes had very
low methylation (Figure 5F). These ﬁndings indicate a
developmental origin for cell type–speciﬁc methylation at
this genomic CGI.
Discussion
A Comprehensive CGI Set
We describe the characterisation of a comprehensive,
veriﬁed CGI set derived from human blood genomic DNA
whole blood DNA detected female-specific CGI methylation. (E) CGIs on the X chromosome (red dots) often showed female-specific methylation. (F)
CGIs on Chromosome 16 (red dots) were indistinguishably methylated between male and female.
(G and H) Confirmation of methylated CGIs by bisulfite genomic sequencing. CGI clones I1387 (G) and I9112 (H) are nonmethylated and methylated,
respectively, as predicted by the microarray data. Open and filled circles represent nonmethylated and methylated CpG sites, respectively. The genomic
locus including annotated transcripts and CpG maps (vertical strokes) are shown above each profile. Each column represents products of amplification
by a single primer pair (brackets below CpG map). Each line corresponds to a sequenced DNA strand. Red bars indicate the location of the MseI
fragment cloned in the CGI library.
(I) The CGI array distinguishes genes inactivated on the X chromosome (inactive) from genes that escape inactivation (escaping). CGIs associated with
inactivated genes (n¼ 103) show significantly higher M values than CGIs at escaping genes (n¼ 14; KS test: p¼ 1.23105).
doi:10.1371/journal.pbio.0060022.g003
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that will be beneﬁcial for studies of CGIs in normal human
tissues and in disease settings. By focusing on CGIs alone, we
excluded ;98% of the genome from our analysis. While it
will ultimately be important to know in detail the methylation
status of whole genomes, this currently represents a technical
challenge that has been addressed only for the small-genomed
plant Arabidopsis [33,34]. These studies used indirect micro-
array-based methods for mapping DNA methylation that
depend upon probes enriched in methylated domains.
Current enrichment methods require clusters of CpG
methylation, which are notably absent from the CpG-
deﬁcient majority of the mammalian genome. As a result,
much bulk genomic DNA is beyond the resolution limit of
this approach. Whole genome bisulﬁte sequencing, the most
direct and reliable method for mapping methylated sites, has
not yet been attempted in any organism. We therefore
decided to study a discrete genomic fraction with evident
biological relevance whose methylation status can be inter-
rogated using microarray-based methods.
To isolate nonmethylated duplex CGIs from total genomic
DNA, we harnessed the binding speciﬁcity of the CXXC
protein domain. Extensive sequencing of the resulting library
conﬁrmed that CGIs represent a discrete fraction of the
human genome with shared DNA sequence characteristics.
The present CGI set supercedes a previous human CGI
library that was prepared in our laboratory using an indirect
afﬁnity puriﬁcation procedure [20]. The initial library was
not comprehensive and appears to have acquired signiﬁcant
levels of non-CGI contamination following ampliﬁcations.
We estimate that the new library represents ;25,000 CGIs, of
which ;60% have been arrayed as full-length single strands
on glass slides. Additional analysis of inserts that initially
failed conventional sequencing strategies will generate an
array that covers the great majority of CGIs that are
nonmethylated in human blood. The choice of blood DNA
as a starting material necessarily excludes from the set any
CGIs that are nonmethylated in germ cells, but densely
methylated in the soma [14]. In the future, it will be
instructive to compare an exhaustive sequence analysis of
this set with comparable sequences isolated by CAP from
sperm DNA.
The library prepared using CAP deﬁnes CGIs based on the
empirical criterion of clustered nonmethylated CpGs, where-
as criteria based purely on base sequence and composition
necessarily ignore methylation status. Comparing our set with
predicted CGIs on the NCBI database shows good overlap
with predictions based on the ‘‘strict’’ algorithm. The CGI
library did, however, identify 23% of CGIs that were negative
by this criterion. This suggests that the software for DNA
sequence-based CGI identiﬁcation misses almost one in four
CGIs that the more biological criterion of CAP is able to
include. Recent CGI analyses identiﬁed large numbers of
human CGI promoters that are enriched in methylation at
lysine 4 of histone H3, a mark of transcriptional activity
[14,35,36]. Since it has been proposed that hypomethylation is
dependent on germ line and early embryonic transcription
[3], we determined the overlap between our CGI set and the
H3K4 sites in human embryonic stem cells [37]. We calculate
that 90% of CGIs in the ﬁltered set (14,318) coincide with
H3K4 methylated promoters that were reported in the
chromatin study. A better test of the relationship between
CGIs and H3K4 methylation islands in ES cells is to exclude
promoters of annotated genes and focus on intra- and
intergenic CGIs. Here again, a high proportion (75%) of CGIs
overlap with H3K4 methylation islands. These ﬁndings are
compatible with the notion that the presence of CGIs is
connected with specialised chromatin conﬁgurations in early
embryonic cells. An intriguing proposal is that H3K4
methylation may be incompatible with docking of de novo
methyltransferases [38]. This could in theory insure that these
regions remain free of CpG methylation at a time when the
rest of the embryonic genome is subject to global methyl-
ation.
We found that 49% of CGIs overlap the TSS of an
annotated gene. In considering the function of the half of
CGIs that are remote from an annotated TSS, it is noteworthy
that several intragenic CGIs have been shown to coincide
with previously unforeseen promoters that initiate bona ﬁde
transcripts [39,40]. This raises the possibility that all CGIs
function as promoters and are therefore TSS-associated [40].
In this connection, it is of interest that genome-wide analysis
by tiling arrays detected over 10,000 unanticipated human
transcripts, many of which may represent noncoding RNAs
[41]. It is conceivable that many inter- and intragenic CGIs
mark promoters that drive the synthesis of these novel
transcripts. The noncoding transcripts XIST and AIR, for
example, whose RNA products play regulatory roles [42–44],
both initiate within CGI promoters. The proximity of many
methylated CGIs to developmentally important genes raises
Figure 4. Tissue-Specific CGI Methylation in a Panel of Human Tissues
(A) Examples of pairwise comparisons using MAP CGI probes derived from blood, brain, muscle, and spleen. Broken red lines indicate threshold M
values used to determine differential CGI methylation.
(B) Frequencies of methylated CGIs in blood, brain, muscle, and spleen. The following catagories are represented: CGIs methylated in all tested tissues
(black); CGIs methylated in more than one tissue tested but not all (green); CGIs methylated in one tissue only (blue); CGIs methylated in one tissue
tested but unclassified in other tissues (white).
(C) Somatically methylated CGIs display a very small but significant reduction in CpG[o/e] (0.75) relative to the whole CGI set (0.77; n¼1,657 and 12,661,
Wilcoxon rank test: p-value: 1.022e11). The histogram shows the CpG[o/e] profile for the total CGI set (white bars) overlaid with the CpG[o/e] profile for
methylated CGIs (red line).
(D–G) Confirmation of candidate CGIs showing evidence of tissue specific methylation by bisulfite genomic sequencing. Layout is as for Figure 3G.
doi:10.1371/journal.pbio.0060022.g004
Table 3. CGI Methylation in Human Tissues
Methylation Status Blood Brain Muscle Spleen
Methylated in all 408 408 408 408
Differentially methylated (multiplea) 149 135 214 247
Differentially methylated (singlea) 50 35 178 140
Unclassified methylation 303 237 392 381
Total 910 815 1,192 1,176
CGIs 14,318 14,318 14,318 14,318
Percentage methylated 6.4 5.7 8.3 8.2
aRefers to number of tissues tested.
doi:10.1371/journal.pbio.0060022.t003
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the possibility that putative CGI transcripts play regulatory
roles during development. Recent analyses of the human
HOX gene cluster highlight the functional importance of
noncoding RNAs [45]. Large numbers of potential CGI
promoters within HOX gene loci may therefore contribute
to the regulation of these complex loci.
CGI Methylation in Normal Tissues
CGI methylation has been extensively studied in cancers
and their derivative cell lines, but relatively less attention has
been paid to the phenomenon in normal tissues. Several
studies have reported somatic CGI methylation, but in early
examples the bioinformatics procedure used to identify these
sequences was often equivalent to the NCBI-relaxed algo-
rithm, which generates a large excess of questionable CGI
candidates. The MASPIN gene, for example, scores as a
methylated CGI promoter by the relaxed criterion [28], but it
is not detected as such either by the NCBI-strict algorithm or
by CAP (unpublished data). A recent report addressing the
methylation status of 16,000 human promoters identiﬁed that
3% of TSS-associated CGIs are normally methylated in
somatic tissue [14], which is somewhat below the levels
observed in our study (7.8%; Table 4). We detect a much
higher frequency of methylation at nonpromoter CGIs
(average ¼ 16%), which are obviously absent from promoter
arrays. In particular, 22% of CGIs near the 39 ends of genes
are methylated. Extensive bisulﬁte sequence analysis [13]
surveyed 512 CGIs on Chrs 6, 20, and 21 and reported 9.2% to
be methylated in somatic tissues. This is similar to the overall
level of 11.6% methylation among 14,318 CGIs detected by
our study (Table 4).
Our ﬁndings raise important questions about the relation-
ship of CGI methylation to gene expression. On the X
chromosome, it is clear that methylated CGIs correlate with
inactivated genes whereas unmethylated CGIs correlate with
genes known to escape inactivation. The generalisation that
CGI methylation silences promoters is therefore supported
(see also [25]). The relevance to gene expression of the
autosomal methylated CGIs identiﬁed here is complicated by
the frequent presence of both methylated and nonmethylated
alleles in a speciﬁc tissue (see below). This means that even if
CGI methylation silences a promoter completely, large
changes in gene expression are not to be expected. Also,
many CGIs are not at promoters of annotated genes, but are
within or between transcription units. Their function with
respect to transcription, if any, may be positive or negative.
Finally, any transcripts originating from these ‘‘orphan’’ CGIs
have yet to be identiﬁed and cannot be tested. For these
reasons, it is difﬁcult to make predictions about the effect of
CGI methylation on global transcription levels. We never-
theless mined published expression microarray data to
determine whether tissues in which a speciﬁc set of promoter
CGIs was methylated expressed the associated genes at a
different level from tissues where the same CGI was
unmethylated. The results showed no obvious correlation
between CGI methylation and expression. This, therefore,
remains an open question that demands detailed analysis of
speciﬁc cases.
Genes that play an important role in development were
prominent among the set of methylated CGIs identiﬁed by
MAP-CGI array hybridization. Out of 109 CGI-associated
genes that contain homeobox-like domains, 27 (;25%) were
unmethylated in at least one tissue compared with ;11% of
all CGI-associated genes (see Table 4). Speciﬁcally, we
identiﬁed 79 CGIs in the four human HOX gene clusters A–
D, of which 22 were methylated in at least one of the tissues
that we tested. Given the relatively small selection of tissues
analysed in the study, the actual frequency of HOX CGI
methylation in all human tissues is likely to be higher than
one in four. Interestingly, methylation of HOX gene CGIs is
also reported in cancers [46], raising the possibility that
cancer CGI methylation patterns mimic patterns that arise
during development. A potential link between normal
development and cancer is suggested by the ﬁnding that
CGIs methylated in cancer preferentially include promoters
that are marked by association with polycomb group proteins
in embryonic stem cells [47–49]. In contrast, we found little
difference between the fractions of all CGIs (5.9% ¼ 845/
14,318) and of methylated CGIs (7.7%¼ 127/1,657) that were
polycomb-associated in embryonic cells [37]. The origins of
CGI methylation in cancer may be distinct from the
mechanisms that lead to CGI methylation in normal tissues.
It was reported that the most CpG-rich CGIs among 512
analysed on Chr 6, Chr 20, and Chr 22 were never methylated,
suggesting that the CpG-richness may protect from methyl-
ation [13]. In a larger CGI set, we detected a very small, but
statistically signiﬁcant, difference in sequence properties
between CGIs that become methylated and those that remain
immune in the tested cell types. The mean CpG[o/e] was 0.75
for methylated CGIs compared with 0.77 for bulk CGIs
(Figure 4C). Bock and colleagues [50] identiﬁed sequence
features that were predictive for CGI methylation, including
speciﬁc repeats, sequence patterns, and DNA structure.
Contrary to predictions of this method, methylated CGIs
were signiﬁcantly depleted in repetitive elements and showed
no difference in predicted base twist. We did, however,
observe small, but statistically signiﬁcant, increases in simple
Table 4. Location of Methylated CGI Relative to Protein-Coding Genes
CGI Gene Association All CGIs Methylated Methylated (%) Differentially Methylated Differentially Methylated (%)
All CGIs 14,318 1,657 11.6 711 5
Genes 11,383 1,209 10.6 501 4.4
59 7,915 620 7.8 243 3.1
39 765 166 21.7 77 10.1
Intragenic 3,478 536 15.4 230 6.6
Intergenic 2,863 435 15.2 203 7.1
doi:10.1371/journal.pbio.0060022.t004
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sequence elements (TGTG/CACA) and base-stacking energy
(see Figure S2). The biological relevance of these minimal
differences is uncertain.
Weber and coworkers [14] identiﬁed ;2,000 promoters out
of 16,000 that were more susceptible to methylation than CGIs
themselves. These so-called ‘‘weakCpG islands’’ had an average
CpG[o/e] ratio intermediate between CGIs and bulk genomic
DNA. We have determined that 75% of weak CpG islands
reported byWeber et al. are absent from the CGI library. Weak
CGIs may be depleted because they are heavily methylated and
therefore not enriched by CAP. Indeed, 22 methylated weak
CpG islands [14] were not detected in our library. Alter-
natively, their relatively low CpG density and somewhat
elevated frequency of Mse1 sites may result in too few CpGs
per fragment for efﬁcient retention by the CXXC matrix.
Composite Methylation of CGIs
Those CGIs that were methylated often showed a mixture
of heavily methylated and nonmethylated strands by bisulﬁte
analysis. There are several possible explanations for compo-
site methylation patterns. Firstly, at the highest level, it is
possible that different individuals contributing to the DNA
pool are polymorphic with respect to this epigenetic mark.
We analysed speciﬁc CGIs in muscle DNA from three
individuals and found evidence of individual variation of
this kind. A large-scale survey would be required to
determine the extent of inter-individual variability. A second
possibility is that cells within the analysed tissue are
heterogeneous with respect to CGI methylation. Each of the
analysed tissues consists of multiple differentiated cell types
that should be analysed separately to address this possibility.
Analysis of three compositely methylated CGIs in blood
showed one that was highly methylated in monocytes, but
weakly methylated in granulocytes, indicating that cell type–
speciﬁc CGI methylation underlay heterogeneous DNA
methylation. A third possible explanation for composite
methylation is monoallelic methylation. A previous study of
149 CGIs on Chr 21q detected three that were mono-
allelically methylated, indicating that this explanation also
accounts for some cases of composite CGI methylation [12].
Methods
Plasmid cloning and recombinant protein puriﬁcation. Cloning of
the His-CXXC construct from murine Mbd1a was described pre-
viously [19]. The MBD construct was subcloned from pET30bhMeCP2
[51]. A fragment of human MeCP2 corresponding to amino acids 76–
167 was PCR-ampliﬁed and ligated into the Nde1 and EcoR1 sites of
pet30b (Novagen) to generate a C terminally His-tagged pet30b-
MeCP2_76–167. Primers: pet30bMeCP2_76–167Nde1 CGG TTC
ATA ACC ATA TGG CTT CTG CCT CCC CCA AAC AGC GG and
pet30bMeCP2_76–167EcoR1 CGG AAG TCA AAG AAT TCT CAT
CAG TGG TGG TGG TGG TGC CGG GA. Recombinant peptides
were puriﬁed from 10 l of induced BL21(DE3)pLysS (Stratagene)
culture on Nickel Charged Fast Flow Chelating Sepharose (GE
Healthcare). The CXXC construct was further puriﬁed by cation
exchange using Sp-Sepharose (GE Healthcare) cation exchange as
previously described [51]. Recombinant protein was bound to Nickel
sepharose prior to longer term storage.
Electrophoretic mobility shift assay (EMSA). CXXC-EMSA was
carried out essentially as described in [19]. Brieﬂy, binding reactions
including 0, 250, 500, 1,000, or 2,000 ng of puriﬁed recombinant His-
CXXC were preincubated in 13binding buffer (53binding buffer: 30
mM Tris-HCl [pH8], 750 mM NaCl, 5 mM DTT, 30 mM MgCl2, 15%
Glycerol, 50 ng/ll BSA, and 0.05 lg/ll of poly(dAdT) (Amersham).
End-labeled CG11[52] probe (1 ng) was added to each reaction and
incubated for a further 25 min. Complexes between probe DNA and
the CXXC domain were resolved on a 1.3% agarose Tris-borate-
EDTA gel and imaged by Phosphor Imager (Molecular Devices).
Human DNA samples. Whole blood was collected from voluntary
donors and used in anonymized pools. Donors were aware of, and
consented to, its use for preparation of DNA. Monocyte and
granulocyte cells were prepared from whole human blood using
Ficoll gradient centrifugation. Whole blood (3 ml) was layered onto
an equivalent volume of Histopaque-1077 Ficoll (Sigma-Aldrich) and
sedimented according to the manufacturer’s instructions. Mononu-
cleocytes were recovered from the plasma-ﬁcoll interphase and
granulocytes from the cell pellet. Whole human blood, monocyte, and
granulocyte DNA was extracted using the Genomic-tip 500/G (Qiagen
10262) genomic DNA puriﬁcation kit. Sperm DNA was prepared as
described [53]. Human skeletal muscle, spleen, and brain genomic
DNAs were purchased from Ambion.
CXXC afﬁnity puriﬁcation. 50–60 mg of recombinant CXXC was
dialysed into W1 buffer (50 mM sodium phosphate buffer [pH8], 300
mM NaCl, 10% glycerol, 15 mM ß-mercaptoethanol, 0.5 mM PMSF),
bound to nickel-charged sepharose, and then washed with 10 column
volumes (CVs) of W1, 10 CVs of W2 (W1þ 10 mM Imadazole), and 10
CVs of W1. Beads were packed onto a 1-ml Tricorn chromatography
column (GE Healthcare). Mse1 digested male DNA (100 lg) pooled
from three individuals was bound to the CXXC column in 90% CA
buffer (20 mM Hepes [pH7.9], 0.1% Triton X-100, 10% glycerol, 0.5
mM PMSF, 10 mM 2-Mercaptoethanol) and 10% CB buffer (CAþ 1 M
NaCl). Equilibrated DNA was then eluted over an increasing NaCl
gradient of 10%–100% CB buffer (Figure 1B). Fractions (3 ml) were
collected and 200 ll of each was precipitated and resuspended in 40
ll 13 TE buffer. Aliquots were PCR- interrogated using Redhot taq
DNA polymerase (Abgene) for XIST (for CACGTGACAAAAGC-
CATG, rev GGTTAGCATGGTGGTGGAC) , NYESO ( for
CCCAGCGTCTGGTAACCATC, revCCACGGGACAGGTACCTC ),
MAO (for CGGGTATCAGATTGAAACAT, rev CTCTAAGCATGGC-
TACACTACA), P48 (for cagaaggtcatcatctgcca, rev tgagttgtttttcat-
cagtcca) under the following conditions: 2 min at 94 8C; followed by
30 cycles of 94 8C for 50 s, Tann 8C for 50 s, 72 8C for 1 min; and a ﬁnal
extension of 72 8C for 7 min. PCR products were resolved on a 1.5%
TAE-agarose gel (Figure 1B). Fractions retaining nonmethylated
CpG-rich Mse1 fragments (Figure 1B) were pooled, diluted with CA
buffer, and re-chromatographed. The relevant fractions were
precipitated and ligated into the NdeI site of pGEM5zf- (Promega).
CGI library sequencing. The clone set was arrayed into 384-well
plates in glycerol for long-term storage. Copies were taken and DNA
prepared for sequencing using a modiﬁed alkaline lysis method. Cells
were lysed in glucose, Tris, EDTA (pH 8) buffer plus NaOH and SDS
and spun through Millipore Montage ﬁlter plates directly into
propan-2-ol to precipitate, followed by elution in water. In all,
172,800 clones were sequenced forward and reverse using T7 and SP6
primers and BigDye V3.1 chemistry, under the following conditions:
30 s at 96 8C, followed by 44 cycles of 92 8C 8 s, 55 8C 8 s, 60 8C 2 min.
Samples were separated using 3730 XL sequencers (Applied
Biosystems). Extraction was performed using sequence analysis v3.1,
and base-called using Phred [54]. DNA sequences were identiﬁed
using NCBI36 and mapped using the ENSMBL Genome Browser
(http://www.ensembl.org/index.html). CGIs that mapped within 1.5 kb
of annotated genes were considered to be gene-associated in order to
Figure 5. Tissue, Cell-Type, and Individual-Specific CGI Methylation at Developmental Gene Loci
(A–B and E–F) Bisulfite genomic sequencing confirmed tissue-specific CGI methylation associated with the developmental genes OSR1 (A) and PAX6 (B).
Multiple CGIs (red boxes) span the HOXC (C) and PAX6 (D) gene loci. Plots of the MAP-CGI array profiles for blood, brain, muscle, and spleen identify
tissue-specific CGI methylation (vertical black bars extending above M ¼ 1.5). Gray bars extending downwards below M ¼ 1.5 (broken blue line)
represent nonmethylated CGIs. The region of PAX6 analysed by bisulfite genomic sequencing (see Figure 5B) is indicated (asterisk in panel D). Tick
marks on the y-axis are spaced at intervals of 1 M value unit. Coding sequences are diagrammed as yellow bars.
(E) Individual-specific CGI methylation internal to the HOXC cluster in muscle DNA.
(F) Cell type–specific methylation is seen at the SEC31B promoter CGI in monocytes and granulocytes derived from whole human blood. Bisulfite
genomic sequencing results (A–B and E–F) are diagrammed as in Figure 3G.
doi:10.1371/journal.pbio.0060022.g005
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take into account mis-annotation of transcription start sites within
poorly deﬁned 59 UTRs.
Microarray fabrication. Amino-linked clone insert amplicons were
generated by vector-speciﬁc PCR in 50 mM KCl, 5 mM Tris (pH 8.5),
and 2.5 mM MgCl2 including 1 M Betaine (10 min at 95 8C; followed
by 35 cycles of 95 8C for 1 min, 60 8C for 15 s, 72 8C for 7 min; and a
ﬁnal extension of 92 8C for 10 min; 59 aminolink forward primer 59 -
CTC ACT ATA ggg CgA ATTg g39 reverse primer 59 -CgC CAA gCT
ATT TAg gTg AC-39). PCR products were ethanol-precipitated and
resuspended in 1 3 microarray spotting buffer (250 mM sodium
phosphate [pH 8.5], 0.01% sarkosyl, 0.1% sodium azide). Arrays were
spotted onto amine-binding slides at 20–25 8C, 40%–50% relative
humidity. After an overnight incubation in a humid chamber, the
slides were blocked (1% ammonium hydroxide for 5 min, followed by
0.1% SDS for 5 min) and denatured (95 8C ddH2O for 2 min), rinsed
in ddH2O, and dried by centrifugation for 5 min at 2503g.
MAP, labeling, and microarray hybridization. Human tissue DNA
pooled from three individuals was digested with Mse1, phosphatase-
treated, and ligated to 5 lmol of phosphorylated catch-linkers
(upper_GGT CCA TCC AAC CGA TCT and lower_CCA GGT AGG
TTG GCT AGA AT phosphate) that had been annealed in 13TE for 5
h. DNA was bound to an MBD chromatography column and afﬁnity-
puriﬁed essentially as described [20]. Fractions containing methylated
CpG-rich Mse1 fragments were pooled and re-chromatographed
before precipitation (Figure 3B). Puriﬁed DNA was resuspended in
13TE and ampliﬁed in parallel with input DNA, using the GC Rich
PCR system (Roche; 2 min at 95 8C; followed by 18 cycles of 95 8C for 1
min, Tann 8C for 1 min, 72 8C for 4 min; and a ﬁnal extension of 72 8C
for 7 min; universal primer_GGT CCA TCC AAC CGA TCT TA).
MAP and Input DNAs (200 ng) were ﬂuorescently labeled by random
priming using the Bioprime labeling kit (Invitrogen), 13 dNTS (103
dNTPS; 2 mM of each dATP, dGTP, dTTP, 1 mM dCTP) and 1.5 nmol
of Cy3 or Cy5-dCTP (GE Healthcare). The labeled Input and MAP
probes were puriﬁed (Invitrogen ‘‘Purelink’’), pooled, and precipi-
tated with 100 lg of human Cot-1 DNA (Invitrogen). Labeled DNA
was resuspended in 400 ll of hybridisation buffer (2XSSC, 50%
deionised formamide, 10 mM Tris-HCl [pH7.5], 10% dextran
sulphate, 0.1% Tween 20), denatured at 100 8C for 10 min, snap-
chilled on ice, and incubated for 1 h at 37 8C. The CGI microarrays
were prehybridised with Cot-1 and herring sperm DNA (Sigma)
before being hybridised for 48 h at 37 8C. Arrays were washed four
times at 37 8C in 13phosphate buffered saline/0.05% Tween 20, three
times at 52 8C in 1 3 saline sodium citrate, twice at RT in 1 3
phosphate buffered saline/0.05% Tween 20, and ﬁnally rinsed in
water, before being dried by centrifugation (500g).
Microarray scanning and data analysis. Arrays were scanned with a
GenePix Autoloader 4200AL (Axon) and then processed using the
GenePix Pro 6.0 (Axon) software package. All subsequent analysis was
carried out with the LIMMA package in the R statistical environment.
Features with poor signal-to-noise ratios were stabilised using a base
value of 1,000 for background-subtracted intensities. Cy3 and Cy5
signals were transformed into M values (log2[red/green]) and
normalised by print-tip loess. Each tissue analysis is represented by
four microarrays comprising two independent replicates with
respective dye swaps. Processed values were averaged through linear
modeling and used to determine the relative enrichment of MAP
DNA relative to Input. An M value of .1.5 was designated as the
threshold for hypermethylation as determined by quantitative PCR
(Figure 3C) and bisulﬁte genomic sequencing (Figures 3G and 3H,
4D–4G, and 5A and 5B). This threshold was conﬁrmed as signiﬁcant
by calculation of a t-statistic by eBayes modeling and BH multiple
testing correction. Differential methylation was deduced when
features displayed an M value .1.5 in one or more tissues and a
differential of 0.75 between tissues (upper boundary capped at M ¼
2.5). To avoid complications due to X chromosome inactivation, CGIs
on sex chromosomes were not included in the analysis. In addition,
spots that gave no signal on the microarray (NA values) and spots
containing DNA in which CpG[o/e] values were ,0.5 were excluded.
Quantitative PCR. Real-time PCR was carried out on MAP and
Input material with iQ SYBR Green Supermix (Bio-Rad) on an
iCycler (Bio-Rad) according to manufacturer’s instructions. For
primer sequences see Table S4.
Bisulﬁte genomic sequencing. Bisulﬁte treatment of genomic DNA
was carried out as described by Feil et al. [55], and prepared for
sequencing as outlined by Suzuki et al. [56]. Genomic DNA (5 lg) was
digested by EcoRI prior to bisulﬁte treatment, and precipitated after
the desulfonation step. Samples were resuspended in 1 3Tris-EDTA
buffer for subsequent PCR and sequencing reactions. Bisulﬁte
speciﬁc primers were designed both manually and with the aid of
the MethPrimer software [3] (sequences are available on request).
PCR was carried out on the bisulﬁte-treated DNA using RedHot Taq
DNA polymerase (Abgene) under the following conditions: 2 min at
94 8C; followed by 40 cycles of 94 8C for 50 s, Tann 8C for 50 s, 72 8C for
1 min; and a ﬁnal extension of 72 8C for 5 min. PCR fragments were
cloned using the Strataclone PCR cloning system (Stratagene) and at
least ten products ampliﬁed (as above) and sequenced (BigDye
Terminator v3.1 Cycle Sequencing Kit; Applied Biosystems). Methyl-
ation status and experimental quality control was carried out with the
aid of BiqAnalyzer [57].
Supporting Information
Dataset S1. Characterization of Human CGIs Identiﬁed as Being
Methylated in One or More Somatic Tissues
Included are sequence characteristics (GþC and CpG[o/e]), gene
association (Gene ID, ENSEMBL nomenclature ), and the methylation
proﬁle in the four tissues tested (categories of methylation are
colour-coded as for Figure 4B). The CpG island identiﬁer (ID)
corresponds to the arrayed CGI fragment. The genomic position of
each CGI (Location) corresponds to the chromosomal coordinates
derived from NCBI build 36.
Found at doi:10.1371/journal.pbio.0060022.sd001 (373 KB XLS).
Figure S1. Sequence Characteristics of CGIs Missed by NCBI-Strict
NCBI-strict relies on base composition to identify CGIs, utilising
threshold values for CpG[o/e] and GþC density (0.6% and 50%,
respectively) as determinants. Boxplots of GþC and CpG[o/e] indicate
that CGIs retained by the CXXC afﬁnity matrix but missed by NCBI-
strict have signiﬁcantly reduced GþC base composition (p-value ,
2.2e16) and CpG[o/e] (p-value , 2.2e16). A nonparametric distribu-
tion was determined using a Shapiro-Wilk test of normality and
subsequent signiﬁcance was determined using a two-sample Kolmo-
gorov-Smirnov test (NCBI-missed n¼ 4,082 and all CGIs n¼ 13,305).
Found at doi:10.1371/journal.pbio.0060022.sg001 (48 KB DOC).
Figure S2. Sequence Properties of Methylated CGIs
Bock and colleagues determined a number of DNA sequence features
that are correlated with DNA methylation at CGIs [50]. Here we
compare the sequence attributes of the methylated and total CGI sets
with respect to DNA structure (stacking energy and base twist) and
speciﬁc repeats (TGTG/CACA). Methylated CGIs show small but
signiﬁcant increase in stacking energy relative to all CGIs (p-value ,
0.001). In contrast we found no signiﬁcant difference in the base twist
of methylated CGIs.
TGTG/CACA speciﬁc repeats were found to be signiﬁcantly enriched
in methylated CGIs (p-value , 0.001; see text for discussion). In
contrast, all repetitive elements (as outlined in Repbase [58]) were
found to be marginally depleted in methylated CGIs (p-value , 0.01,
Wilcoxon rank sum test, n ¼ 4,082 and 10,236). Stacking energy and
base twist were calculated using the EMBOSS b-twisted program with
default settings[59]. All distributions were tested for parametric
distribution by the Shapiro-Wilk test of normality. Nonparametric
signiﬁcance values were determined using the Wilcoxon rank sum
test (n ¼ 4,082 and 10,236).
Found at doi:10.1371/journal.pbio.0060022.sg002 (66 KB DOC).
Table S1. Gene Association: CpG Islands Missed by NCBI-Strict
All CGIs (n ¼ 4,082) retained by the CXXC afﬁnity matrix but not
predicted by NCBI-strict were mapped relative to protein-coding
genes. Gene overlap indicates the spatial association of CGIs relative
to protein-coding genes.
Found at doi:10.1371/journal.pbio.0060022.st001 (27 KB DOC).
Table S2. Methylated CGIs on Chromosome 16 and Chromosome X
in Human Whole Blood DNA
CGI arrays hybridised with MBD probe from male and female human
blood DNA identify extensive methylation of X-linked CGIs. In
contrast, the percentage of X-linked CGIs methylated on the single
male X chromosome was comparable to the levels found on the
human autosomes, as illustrated for Chr16.
Found at doi:10.1371/journal.pbio.0060022.st002 (30 KB DOC).
Table S3. Developmental Gene Categories Are Associated with
Differentially Methylated CpG Islands
Ontology terms for gene-associated CGIs were compared with those
for differentially methylated CGI-genes. Genes involved in devel-
opmental processes such a neurogenesis and segmentation are
PLoS Biology | www.plosbiology.org January 2008 | Volume 6 | Issue 1 | e220049
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signiﬁcantly enriched and include transcriptional regulators such as
homeobox genes. Signiﬁcantly enriched biological processes and
molecular functions were determined using the Web-based Panther
classiﬁcation system (http://www.pantherdb.org/)[60].
Found at doi:10.1371/journal.pbio.0060022.st003 (41 KB DOC).
Table S4. Quantitative PCR Primers for Microarray Validation
CGI ID: CpG island identiﬁers which correspond to the CGI library.
M value: Log2[MBD/Input] for human blood microarray experiment.
Found at doi:10.1371/journal.pbio.0060022.st004 (36 KB DOC).
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